Skip to main content
CMS.gov Centers for Medicare & Medicaid Services CMS.gov Centers for Medicare & Medicaid Services opens in new window
CMS.gov Centers for Medicare & Medicaid Services
Centers for Medicare & Medicaid Services

Main header

  • About Us
  • Newsroom
  • Data & Research
Newsroom

Newsroom_Navigation

  • Press Kit
  • Data
  • Contact
  • Blog
  • Podcast

 

 

 

Press release

AFFORDABLE CARE ACT SUNSHINE RULE INCREASES TRANSPARENCY IN HEALTH CARE

Dec 14, 2011
  • Affordable Care Act
  • Data
  • DMEPOS suppliers
  • Fraud, waste, & abuse
  • Hospitals
  • Medicaid & CHIP
  • Medicare Parts A & B
  • Policy
  • Prescription drugs

Share

opens in new window opens in new window opens in new window

AFFORDABLE CARE ACT SUNSHINE RULE INCREASES TRANSPARENCY IN HEALTH CARE

The Centers for Medicare & Medicaid Services (CMS ) announced today a proposed rule that will increase public awareness of financial relationships between drug and device manufacturers and certain health care providers.  This is one of many steps under the Affordable Care Act designed to increase transparency in the health care system, which can lead to better care at lower costs.

 

“When people are faced with the difficult task of choosing the right doctor, they need all the information they can gather. If your doctor is taking money from manufacturers of prescription drugs, suppliers of wheelchairs or other devices, you deserve to know about it,” said Peter Budetti, M.D. CMS deputy administrator for Program Integrity.  “Disclosure of these relationships will discourage the inappropriate influence on clinical decision-making that sometimes occurs while still allowing legitimate partnerships.”

 

The proposed rule would require manufacturers of drugs, devices, biologicals, and medical supplies covered by Medicare, Medicaid, or the Children’s Health Insurance Program to report to CMS payments or other transfers of value they make to physicians and teaching hospitals.  The proposed rule would also require manufacturers and group purchasing organizations (GPOs) to disclose to CMS physician ownership or investment interests.

 

This increased transparency is intended to help reduce the potential for conflicts of interest that physicians or teaching hospitals might face as a result of their relationships with manufacturers.

 

Drug and biologic manufacturers, medical device or supply manufacturers, and GPOs would be affected by the new reporting requirements. These organizations, as well as the physicians and teaching hospitals, would be allowed an opportunity to review and correct information prior to its publication.

 

The Affordable Care Act provides that violators of the reporting requirements will be subject to civil monetary penalties (CMPs), capped at $150,000 annually for failing to report, and $1,000,000 for knowingly failing to report.

 

 CMS is proposing that data collection will not begin on Jan. 1, 2012 and that manufacturers and GPOs do not need to begin data collection until final regulations are issued.   Depending on the timing of the final rule, CMS is proposing that manufacturers and GPOs will be required to submit a partial year on Mar. 31, 2013.  Once the data has been submitted, CMS will aggregate manufacturer submissions at the individual physician and teaching hospital level, provide them with a 45-day period to confidentially review and, if necessary, correct the data, and make the data publicly available by Sep. 30, 2013.

 

CMS will accept comments on the proposed rule until Feb. 17, 2012, and will respond to them in a final rule to be published in 2012.

 

The proposed rule can be downloaded at:

https://s3.amazonaws.com/public-inspection.federalregister.gov/2011-32244.pdf 

 

 

# # #

 

 

Please note: This rule is scheduled to be published on  12/19/2011 and will be available on this page http://www.federalregister.gov/articles/2011/12/19/2011-32244/transparency-reports-and-reporting-of-physician-ownership-or-investment-interests-medicare-medicaid

  • Previous
  • Next

Related Releases

  • Notice of Benefit and Payment Parameters for 2022 Final Rule Fact Sheet
    Jan 14, 2021
  • CMS Continues Building Better, More Affordable Insurance Marketplace with Payment Notice for 2022 Coverage Year
    Jan 14, 2021
  • 2021 Federal Health Insurance Exchange Weekly Enrollment Snapshot: Final Snapshot
    Jan 12, 2021
  • CMS Releases Final Snapshot for the 2021 Federal Exchange Open Enrollment Period
    Jan 12, 2021
  • Trump Administration Marks End of Fourth Successful Open Enrollment Period
    Dec 18, 2020

Contact us

CMS News and Media Group
Catherine Howden, Director
Brian Leshak, Deputy Director
Jason Tross, Deputy Director

Media Inquiries Form
202-690-6145

Get email updates

Sign up to get the latest information about your choice of CMS topics in your inbox. Also, you can decide how often you want to get updates.

CMS & HHS WEBSITES

  • Medicare.govopens in new window
  • MyMedicare.govopens in new window
  • Medicaid.govopens in new window
  • InsureKidsNow.govopens in new window
  • HealthCare.govopens in new window
  • HHS.govopens in new window

HELPFUL LINKS

  • Acronyms
  • Archive
  • Contacts
  • Glossary
  • Privacy policy
  • Privacy settings

RSS FEEDS

  • Newsroom
  • Blog
  • Podcast
U.S. Department of Health & Human Servicesopens in new window Centers for Medicare & Medicaid Servicesopens in new window

A federal government website managed and paid for by the U.S. Centers for Medicare & Medicaid Services.

7500 Security Boulevard, Baltimore, MD 21244

opens in new window opens in new window opens in new window

TOOLS

  • Web policiesopens in new window
  • Plain languageopens in new window
  • No Fear Actopens in new window
  • Freedom of Information Actopens in new window
  • Inspector Generalopens in new window